Hepcidin, the iron-regulatory hormone, determines plasma iron concentrations and total body iron content. Hepcidin, secreted by hepatocytes, functions by controlling the activity of the cellular iron exporter ferroportin, which delivers iron to plasma from intestinal iron absorption and from iron stores. Hepcidin concentration in plasma is increased by iron loading and inflammation and is suppressed by erythropoietic stimulation and during pregnancy. Hepcidin deficiency causes iron overload in hemochromatosis and anemias with ineffective erythropoiesis. Hepcidin excess causes iron-restrictive anemias including anemia of inflammation. The development of hepcidin diagnostics and therapeutic agonists and antagonists should improve the treatment of iron disorders.
CITATION STYLE
Nemeth, E., & Ganz, T. (2023, January 27). Hepcidin and Iron in Health and Disease. Annual Review of Medicine. Annual Reviews Inc. https://doi.org/10.1146/annurev-med-043021-032816
Mendeley helps you to discover research relevant for your work.